Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology modelJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-0227OAAI
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer三阴性乳腺癌中阿特珠单抗和nab-紫杉醇疗效的定量系统药理学模型预测JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-02-1233OAAI
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP modelJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-08-2739OAAI